Cantor Fitzgerald Comments on RCUS FY2026 Earnings
Arcus Biosciences, Inc. (NYSE:RCUS – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2026 earnings per share estimates for Arcus Biosciences in a research report issued on Monday, June 9th. Cantor Fitzgerald analyst L. Watsek anticipates that the company will post earnings of ($3.93) per share for the year. The consensus estimate for […]
